RecruitingPhase 3NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sponsor: Novo Nordisk A/S
Brooklyn, NY · New York, NY · +36 more sites
2 recruiting sickle cell disease studies with a site in Brooklyn, NY.
Sponsor: Novo Nordisk A/S
Brooklyn, NY · New York, NY · +36 more sites
Sponsor: Novo Nordisk A/S
Brooklyn, NY · Mount Kisco, NY · +47 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.